Todd Levine, MD, Chief Medical Officer and Co-Founder of CND Life Sciences was interviewed last month about the Syn-One Test® in a three-part series on the Lewy Body Roller Coaster podcast.
Biogen and Alectos Therapeutics have announced that they will collaborate on the development of AL01811, a novel β-glucosidase 2 (GBA2) inhibitor and first-in-class small molecule with the potential to become a disease-modifying treatment for Parkinson’s disease.
“It wasn’t until Robin’s autopsy that we got an accurate diagnosis,” explains Susan Schneider Williams, widow of the late comedian, in a talk she gave at Life Itself—a health and wellness conference presented in partnership with CNN.
Previous research has examined whether levels of alpha-synuclein autoantibodies (α-syn AAb) differ between patients with Parkinson’s disease and healthy controls to determine its utility as a biomarker, however, results have been inconclusive.
Dr. Christopher H. Gibbons, Senior Scientific Advisor of CND Life Sciences, was recently interviewed in a Medscape Neurology story titled “Skin Testing May Help Detect Movement Disorders.”
A primary challenge in the diagnosis of neurological disorders is differentiating between conditions that share clinical features. Absent of a clear diagnosis, proper
and effective patient care is hindered. Therefore, there is a great need for accessible diagnostic tools that help provide clarity to diagnosing clinicians.
CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).
Dr. Todd Levine, Chief Medical Officer and Co-Founder of CND Life Sciences will present as part of a Controversies in Movement Disorders panel discussion at 6:30 pm on May 23, 2022, in Punta Gorda, FL.
In honor of national Parkinson’s month, CN2 news in Rock Hill, SC featured Memory & Movement Charlotte, a medical practice focused on Parkinson’s disease and other neurological conditions, where Medical Director Dr. Sanjay Iyer has recently started offering the Syn-One Test to his patients.
Researchers from La Jolla Institute for Immunology have discovered a genetic signature on the circulating T cells of patients with Parkinson’s disease, which they hope can provide new avenues of research for potential treatments.